glp 1 and microbiome Interplay of gut microbiota, glucagon-like peptide receptor agonists, nutrition: New frontiers in metabolic dysfunction-associated steatotic liver disease therapy A Specific Gut Microbiota Dysbiosis

According to the UK Summary of Product Characteristics (SmPC), it's important to note that even after gallbladder removal, patients should be aware of potential acute biliary disease and pancreatitis risks

GLP-1 injections are a wild trend these days

Although all of these diets differ in some way, with different pros and cons, there seems to be agreement about a few things: Avoid processed food as much as possible

The SOUL cardiovascular outcomes trial (CVOT) demonstrated a 14% relative reduction in risk of MACE in patients treated with Rybelsus 14 mg orally once daily for approximately 5 years compared to those who received placebo

The psychiatric-metabolic connection is real